Lance Shinn
Internal Medicine · Daniels, WVNPI 1316468192
Payments from drug & device makers
Across 151 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$931
- Medtronic$323
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$293
- AbbVie$265
- Averitas Pharma Inc.$208
- Curonix LLC$191
- plus $520 from 15 others
What the payments were for
- Food & beverage$2,730100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 60 | $931 |
| Medtronic | 11 | $323 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $293 |
| AbbVie | 19 | $265 |
| Averitas Pharma Inc. | 10 | $208 |
| Curonix LLC | 5 | $191 |
| Johnson & Johnson | 1 | $74 |
| Relievant Medsystems, Inc. | 3 | $55 |
| Pfizer | 3 | $51 |
| Abbott | 2 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| GSK | 2 | $35 |
| Novartis | 2 | $33 |
| Lundbeck LLC | 2 | $31 |
| Lilly USA, LLC | 2 | $31 |
| Exact Sciences | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Nevro Corp. | 1 | $24 |
| Boston Scientific | 1 | $18 |
| Amgen | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$175
How this compares
$2,730 in reported general payments places this provider in the 80th percentile of 573 internal medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 95 | $183,427 |
| EliquisApixaban | 69 | $82,954 |
| MounjaroTirzepatide | 37 | $46,148 |
| JanuviaSitagliptin Phosphate | 20 | $34,033 |
| RybelsusSemaglutide | 12 | $28,956 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $28,340 |
| JardianceEmpagliflozin | 21 | $22,923 |
| FarxigaDapagliflozin Propanediol | 25 | $19,457 |
| WegovySemaglutide | 13 | $19,297 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 16 | $14,456 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $10,311 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $5,227 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $4,893 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 140 | $4,369 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 117 | $3,485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Wegovy | $931 | $231,680120 claims |
| PfizerEliquis | $51 | $82,95469 claims |
| Lilly USA, LLCMounjaro | $31 | $46,14837 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $35 | $33,56654 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $41 | $14,45616 claims |
| AbbVieSynthroid | $265 | $1,17427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 573 internal medicine providers in West Virginia.
Other internal medicine in Daniels
- Ward PaineMorgantown$5.1M
- William ChapmanCharleston$1.7M
- Mustafa AwiliHuntington$906K
- David PickeringParkersburg$694K
- Laura DavissonMorgantown$118K
- Michael BrumageClendenin$87K
- Govind PatelFairmont$59K
- Lynn SmithLewisburg$31K
- Bisher MustafaHuntington$28K
- Johny AlencherryMartinsburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.